Cryptococcal Infections: Clinical Trials

4 trials for Cryptococcal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Withdrawn 1
Phase 21Withdrawn 1
Phase 31Terminated 1

Follow Cryptococcal Infections: new trials by email Literature Review of Cryptococcal Infections trials Research Report on Cryptococcal Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Advanced HIV Disease Differentiated Care Model in Malawi
Enhanced package for AHD care - Opportunistic Infections, HIV-Related, Cryptococcal Infections
Not applicableCompletedElizabeth Glaser Pediatric AIDS Foundation7002021-06-012026-09-10
Efficacy and Safety of Oral Encochleated Amphotericin B for the Treatment of Cryptococcal Infection
Encochleated Amphotericin B - Cryptococcal Infections
Phase 1 / Phase 2WithdrawnMatinas BioPharma Nanotechnologies, Inc.2018-10-012019-03-08
Ampholipad Real-World Data in Taiwan
Aspergillus Infection, Febrile Neutropenia
CompletedTaiwan Liposome Company1022018-09-092021-01-07
Cryptococcal Antigen Screening Plus Sertraline
Sertraline, Placebo Oral Tablet, Fluconazole - Cryptococcosis, Cryptococcal Infections
Phase 3TerminatedUniversity of Minnesota222017-11-152020-06-09

Narrower conditions

AIDS-Related Opportunistic Infections (2)  ·  AIDS-related Kaposi sarcoma (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Aspergillosis (1)  ·  Candidiasis (1)  ·  Cryptococcosis (1)  ·  Febrile Neutropenia (1)  ·  Infections (1)  ·  Mycoses (1)

Broader conditions

Bacterial Infections and Mycoses (2)  ·  Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  HIV Infections (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Infections (2)  ·  Lentivirus Infections (2)  ·  Opportunistic Infections (2)  ·  RNA Virus Infections (2)  ·  Retroviridae Infections (2)  ·  Virus Diseases (2)  ·  Agranulocytosis (1)  ·  Cytopenia (1)  ·  Genital Diseases (1)

Interventions

Fluconazole (1)  ·  Sertraline (1)

Sponsors

Elizabeth Glaser Pediatric AIDS Foundation (1)  ·  Matinas BioPharma Nanotechnologies, Inc. (1)  ·  Taiwan Liposome Company (1)  ·  University of Minnesota (1)

Countries

Malawi (1)  ·  Taiwan (1)  ·  Uganda (1)

Top investigators

Appolinaire Tiam, MBChB, MMed, PhD (1)  ·  Carl Brown, PhD (1)  ·  David R Boulware, MD, MPH (1)  ·  Elizabeth K Nalintya, MBChB MPH (1)  ·  Radha Rajasingham, MD (1)  ·  Rose Nyirenda, MPH, PhD (1)  ·  Tafese Beyene Tufa (1)  ·  Thulani Maphosa, PhD (1)

Results publications

PMID 32415846, PMID 38041058

NIH funding

U01AI125003 (1)